Table 3.

Relationship between fascin intensity and clinicopathologic characteristics in all patients

Status of fascin expressionWeak 1+ (n = 82), n (%)Moderate 2+ (n = 85), n (%)Intense 3+ (n = 33), n (%)P
Age, y
    <6544 (53.7)38 (44.7)17 (51.5)0.418
    ≥6538 (46.3)47 (55.3)16 (48.5)
Gender
    Male59 (72.0)73 (85.9)30 (90.9)0.100
    Female23 (28.0)12 (14.1)3 (9.1)
Primary tumor
    T1/T241 (50.0)47 (55.3)11 (33.3)0.100
    T3/T441 (50.0)38 (44.7)22 (66.7)
Regional lymph nodes
    N029 (35.4)34 (40.0)10 (30.3)0.594
    N153 (64.6)51 (60.0)23 (69.7)
Distant metastasis
    M069 (84.1)70 (82.4)28 (84.8)0.928
    M113 (15.6)15 (17.6)5 (15.2)
Stage
    I/IIA/IIB46 (56.1)43 (50.6)14 (42.4)0.404
    III/IV36 (43.9)42 (49.4)19 (57.6)
Histology
    Well differentiated20 (24.4)18 (9.3)4 (4.7)0.692
    Moderately differentiated42 (51.2)46 (10.8)19 (23.0)
    Poorly differentiated20 (24.4)21 (12.4)10 (9.0)
Location
    Upper12 (14.6)18 (21.2)7 (21.2)0.802
    Middle47 (57.3)44 (51.8)16 (48.5)
    Lower23 (28.0)23 (27.1)10 (30.3)